We have some exciting news to share! The Motley Fool UK has now become The Twelfth Magpie -- an independent, UK-owned company, led by our long-serving UK management team — Mark Rogers, Chris Nials and Heather Adlington. In practical terms, it’s the same team you know, now fully focused on serving our UK readers and members.

Just as importantly, our approach remains unchanged: long-term, jargon-free, and on your side. This site is our new home, and there will be extra tweaks made across the coming few days as we settle in. So if anything looks a little off, please bear with us!

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

What This Top Dividend Portfolio Is Holding Now: GlaxoSmithKline plc, Centrica PLC and Vodafone Group plc

GlaxoSmithKline plc (LON:GSK), Centrica PLC (LON:CNA) and Vodafone Group plc (LON:VOD) are the heavyweight holdings of Murray Income Trust plc (LON:MUT).

| More on:

You’re reading a free article with opinions that may differ from The Twelfth Magpie’s Premium Investing Services. Become a member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn more, and get a free 'Best Buy Now' stock!.

Murray Income Trust (LSE: MUT) announced its annual results last month. The board lifted the dividend by 3.4% to record 30 years of unbroken growth. At a current share price of 762p the trailing yield is 4%.

Picking great dividend shares has helped Murray Income outperform the FTSE All-Share Index over the past three, five and 10 years.

Should you buy Centrica Plc shares today?

Before you decide, please take a moment to review this report first. Despite ongoing uncertainties from US tariffs to global conflicts, Mark Rogers and his team believe many UK shares still trade at substantial discounts, offering savvy investors plenty of potential opportunities to learn about.

That’s why this could be an ideal time to secure this valuable research – Mark’s analysts have scoured the markets to reveal 5 of his favourite long-term ‘Buys’. Please, don’t make any big decisions before seeing them.

Let’s take a look at the trust’s current top three holdings: GlaxoSmithKline (LSE: GSK), Centrica (LSE: CNA) and Vodafone (LSE: VOD) (NASDAQ: VOD.US).

GlaxoSmithKline

GlaxoSmithKline (GSK) is a longstanding favourite of income investors. The UK’s top pharmaceuticals group has continued to increase its dividend despite the recent years of patent expiries and threat from generic rivals.

Free cash flow has been tight of late but GSK has a strong late-stage pipeline of new treatments, and recent agreements to sell non-core drinks brands Lucozade and Ribena, and thrombosis brands Arixtra and Fraxiparine, will bring in handy cash of £2bn.

Analysts are forecasting a 4.2% increase in the dividend for the current year, giving a 5% yield at a recent share price of 1,540p.

Centrica

Shares of Centrica, the owner of British Gas, have come under the cosh recently as a result of Ed Miliband’s proposal to break up the ‘Big Six’ utilities and cap energy bills. High-profile fund manager Neil Woodford — Centrica’s largest shareholder — has slammed the proposal as “economic vandalism”.

Now could be a good time to invest in Centrica, if you believe Labour’s proposal is unworkable on the basis that, as Woodford says: “If Centrica and SSE cannot make any money supplying electricity to the retail market then they won’t supply it. The lights will go off …”

Centrica has been a reliable dividend payer, and the recent drop in the share price has pushed up the yield. With the shares trading at 368p, and analysts forecasting a 6% rise in this year’s dividend, the prospective income is 4.7%.

Vodafone

There was big news last month with the coming to fruition of Vodafone’s long-mooted sale of its 45% interest in US company Verizon Wireless to Verizon Communications.

On announcing the sale — worth a whopping $130bn — Vodafone said “The Board …  intends to increase the total 2014 financial year dividend per share by 8% to 11p”. At a recent share price of 217p that represents a yield of 5.1%.

Such an event as the game-changing sale of Verizon Wireless inevitably leads to some uncertainty. However, as far as the dividend is concerned, Vodafone has said that after the upcoming 11p a share payout, the board “intends to grow [the dividend] annually thereafter”.

> G A Chester does not own any shares mentioned in this article. The Motley Fool has recommended shares in GlaxoSmithKline and Vodafone.

More on Investing Articles

Black woman using smartphone at home, watching stock charts.
Investing Articles

3 crazy Nasdaq growth stocks I’m avoiding like the plague in June

This trio of Nasdaq shares offers eye-popping growth potential across space and artificial intelligence. What's not to like?

Read more »

Investing Articles

Is this former stock market hero now the ultimate FTSE 100 buy and hold?

This UK blue chip was the darling of the stock market for years, but lately it's struggled and investors have…

Read more »

Diverse group of friends cheering sport at bar together
Investing Articles

3 shares to consider buying for the 2026 World Cup

The 2026 World Cup could throw up some lucrative opportunities for investors. Here are three shares to consider buying for…

Read more »

The Milky Way at night, over Porthgwarra beach in Cornwall
Investing Articles

Is the SpaceX IPO the best growth stock opportunity in a generation?

How about a mix of space exploration, satellite communications, and artificial intelligence? That's what SpaceX stock is all about.

Read more »

Red lorry on M1 motorway in motion near London
Investing Articles

No longer just a grocer: here’s how a shift in strategy could help Tesco shares hit new highs

Mark Hartley looks into the strategic data-driven transition that's helping Tesco become more than just a grocer, and could send…

Read more »

Middle-aged black male working at home desk
Investing Articles

British American Tobacco’s share price slumps 4%! How’s that happened?

British American Tobacco's share price has sunk today, making it the FTSE 100's worst performer. Is it time for dip…

Read more »

A hiker and their dog walking towards the mountain summit of High Spy from Maiden Moor at sunrise
Investing Articles

7.5% yields! Here are 2 very different dividend stocks to consider buying in June

Dividend stocks can be great investments, but they’re not all the same. Stephen Wright outlines two for passive income investors…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

Takeover talk! But how much is a £10,000 investment in easyJet shares 5 years ago worth today?

How can UK stocks with high dividend yields help investors earn a meaningful second income from the price of a…

Read more »